A Study of Olaparib and Durvalumab in Prostate Cancer
Clinical trial NCT03810105 · TERMINATED
Trial details
- NCT number
- NCT03810105
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2023-07-06
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.